MEDICAL DEVICES · SERVICE DETAILS

Device classification and pathway assessment

Product codes, classification codes and possible United States listing routes are checked against intended uses, technical principles and corporate roles.

Applicability and scope of work are determined on the basis of products, business activities and available information, and costs and delivery are subject to mutually confirmed project arrangements.

SERVICE OVERVIEW

What does this service help with?

Product codes, classification codes and possible United States listing routes are checked against intended uses, technical principles and corporate roles.

WHO MAY NEED IT

Who should consider this service?

The manufacturer, labeler and team responsible for compliance in the United States market; Specific obligations are judged by the facts of the activities and products of each subject.

SCOPE & APPROACH

What we typically discuss

Identify information gaps before agreeing on documentation and responsibilities.

01

Product vs. declaration

Combination of uses, application of crowds, use of the environment, working principles and labels, checking whether they belong to instruments and possible regulatory boundaries.

02

Classification and Path Comparison

Queries classification codes, product codes and related listing records, distinguishing between exemptions, routes such as 510(k), De Novo, PMA and issues to be identified.

03

Assessment of records and next steps

Provide a basis, preliminary judgement, information gaps and suggested pathways; If formal FDA feedback is required, another 513(g) or communication arrangements apply.

GET READY

What to prepare before contacting us

If documents are incomplete, share the product and current stage first. You can provide the remaining details later.

  • Product description, model and technical parameters
  • Expected use, labelling and description
  • Similar product trails, existing FDA communication or declaration records
HOW TO START

From initial review to engagement

STEP 01

Confirm product and project status

Check products, business roles, existing records and issues to be addressed.

STEP 02

Verification of information and agreed scope

Information gaps, responsibilities of the parties, costs and delivery arrangements are set out on this page.

STEP 03

Undertaking contractual work

Collaboration around the assessment, documentation, submission or maintenance of identified issues to be resolved.

STEP 04

Review and successor arrangements

Delivery of agreed records or recommendations with clear applicable responsibility for subsequent maintenance.

Registration, listing, submission of or obtaining supporting documents from the database does not amount to FDA approval or full compliance determination. The results of the pre-market declaration are determined by the FDA; Specific exemptions, technical and maintenance requirements should be reconciled with products.

TIMING & FEES

Timing and fees

Information reviewed:Fee period: FY 2027, October 1, 2026 through September 30, 2027. For other charges, use the FDA rules as of the review date.

Timing and preparation

Document preparation

Assessment plans based on use, technical rationale, level of classification disputes and availability of information on the same product.

FDA processing

No uniform number of days for completion of the FDA review for this advisory or information service; If a separate regulatory application is submitted, the official processing time is checked according to the corresponding procedures.

Fee breakdown

FDA fees

No FDA application fee for internal classification advice; If a separate 513 (g) is submitted, the FY 2027 standard fee US$ 8,596 is determined to be US$ 4,298 for small business fees, and the scope of the application is separately confirmed.

Service fees

Consulting and filing are quoted separately from FDA fees, based on the number of products, completeness of the records, work scope, response rounds and service term.

Other possible costs

Testing, translation, software and other third-party work are quoted separately where needed.

OFFICIAL SOURCES

FDA Official Basis and Check Date

Data check: 2026-11-05. The specific application conditions and submission requirements are based on the current official statement of the FDA and the product facts.

START WITH YOUR PRODUCT

Provide products and current information and confirm the next steps.

Product codes, classification codes and possible United States listing routes are checked against intended uses, technical principles and corporate roles.